CONMED (CNMD) PT Raised to $45 at Piper Sandler
Get Alerts CNMD Hot Sheet
Price: $49.43 --0%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 14 | New: 22
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 14 | New: 22
Join SI Premium – FREE
Piper Sandler analyst Matt O'Brien raised the price target on CONMED (NYSE: CNMD) to $45.00 (from $39.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Goldman Sachs Downgrades China Resources Cement Holdings (1313:HK) (CARCY) to Sell
- China Coal Energy Co Ltd. (601898:CH) PT Lowered to RMB22 at Goldman Sachs
- Angang Steel Company Limited (0347:HK) (ANGGF) PT Lowered to HK$1 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share